logo

A Rundown of Dravet Syndrome Drugs In The Pipeline

1 / 8
Biocodex
Biocodex

Privately-held Biocodex S.A. markets a drug for Dravet syndrome by the name Diacomit in Europe, Canada, and Japan.

Diacomit, known generically as Stiripentol, is available in dosage of 250mg and 500mg, both in hard capsules and powder for oral suspension in sachets.

This drug is not approved in the U.S.